This issue serves as a timely review of both the genetic and genomic factors resulting in a predisposition to human cancer. There is now strong evidence to support the use of genetic testing for cancer predisposition in the practice of preventive medicine, and at the same time, there is emerging new literature defining the role of genomic approaches to assessment of cancer predisposition. Articles address predisposition syndromes in the areas of breast cancer, lower GI cancer, genitourinary cancer, pediatric cancer, endocrine cancer, and hematologic malignancy.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Prof. Robson is a board-certified medical oncologist who specializes in the identification and management of individuals who have inherited an increased risk for cancer. He concentrates on helping men and women with cancer incorporate genetic information into their treatment plan. For those who are at increased risk, but have not been diagnosed, he works to develop a plan that will help them either prevent the development of cancer, or limit its impact if it occurs. Along the same lines, his research focus has studied the best ways to use genetic information to improve the outcomes of those with or at risk for hereditary cancers of all types. Consistent with the goals, he pursues in his clinical genetics work, his oncology practice is weighted toward the management of young women with breast cancer, especially hereditary breast cancer. As part of that practice, he participates in the development of new treatments, such as PARP inhibitors, which may be particularly useful for this group of women. Finally, he also maintains a separate practice where he coordinates screening for women with mutations in BRCA1 or BRCA2
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: Chiron Media, Wallingford, Vereinigtes Königreich
Hardcover. Zustand: New. Bestandsnummer des Verkäufers 6666-ELS-9781437722048
Anzahl: Mehr als 20 verfügbar
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
Hardcover. Zustand: Brand New. 1st edition. 211 pages. 9.00x6.00x0.50 inches. In Stock. Bestandsnummer des Verkäufers __1437722040
Anzahl: 2 verfügbar
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
Zustand: New. pp. 210. Bestandsnummer des Verkäufers 6747973
Anzahl: 3 verfügbar
Anbieter: Books Puddle, New York, NY, USA
Zustand: New. pp. 210. Bestandsnummer des Verkäufers 261132698
Anzahl: 3 verfügbar
Anbieter: Brook Bookstore On Demand, Napoli, NA, Italien
Zustand: new. Questo è un articolo print on demand. Bestandsnummer des Verkäufers cc189a92668f9274a1f77f2343e259d5
Anzahl: Mehr als 20 verfügbar
Anbieter: Biblios, Frankfurt am main, HESSE, Deutschland
Zustand: New. pp. 210. Bestandsnummer des Verkäufers 181132688
Anzahl: 3 verfügbar
Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Deutschland
Buch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This issue serves as a timely review of both the genetic and genomic factors resulting in a predisposition to human cancer. There is now strong evidence to support the use of genetic testing for cancer predisposition in the practice of preventive medicine, and at the same time, there is emerging new literature defining the role of genomic approaches to assessment of cancer predisposition. Articles address predisposition syndromes in the areas of breast cancer, lower GI cancer, genitourinary cancer, pediatric cancer, endocrine cancer, and hematologic malignancy. 210 pp. Englisch. Bestandsnummer des Verkäufers 9781437722048
Anzahl: 2 verfügbar
Anbieter: THE SAINT BOOKSTORE, Southport, Vereinigtes Königreich
Hardback. Zustand: New. New copy - Usually dispatched within 4 working days. Bestandsnummer des Verkäufers B9781437722048
Anzahl: Mehr als 20 verfügbar
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - This issue serves as a timely review of both the genetic and genomic factors resulting in a predisposition to human cancer. There is now strong evidence to support the use of genetic testing for cancer predisposition in the practice of preventive medicine, and at the same time, there is emerging new literature defining the role of genomic approaches to assessment of cancer predisposition. Articles address predisposition syndromes in the areas of breast cancer, lower GI cancer, genitourinary cancer, pediatric cancer, endocrine cancer, and hematologic malignancy. Bestandsnummer des Verkäufers 9781437722048
Anzahl: 2 verfügbar